4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-21-034186
SVP & Chief Commercial Officer sold 6,085 shares at $18.30 ($111,356)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| NORTHCOTT JOHN SVP & Chief Commercial Officer | 2021-05-17 | Sale | −6,085 | $18.30 | $111,356 | 207,107 | D |
| Open-market sales · 6,085 sh · avg $18.30 · $111,356 | |||||||
Loading xslF345X03/doc4.xml…